
HCAT Stock Forecast & Price Target
HCAT Analyst Ratings
Bulls say
Health Catalyst Inc has demonstrated a significant improvement in its earnings power over the past seven years, evidenced by an increase in EBITDA alongside a growing client base. The company benefits from a strong Technology segment, which primarily drives revenue through cloud-based subscriptions and maintenance, as well as a Professional Services segment that adds value through expert implementation and strategic advisory services. Additionally, favorable trends in hospital volumes and an uptake in purchases of Health Catalyst modules from executives suggest potential for continued revenue growth and improving margins, contributing to a positive outlook for the company.
Bears say
Health Catalyst Inc has experienced a slowdown in total revenue growth, raising concerns about its ability to maintain robust revenue and EBITDA expansion in an already highly penetrated Total Addressable Market (TAM) among health systems. Despite the company generating approximately 90% of its revenue from recurring sources, the decline in net dollar-based retention levels indicates potential weaknesses in customer loyalty and satisfaction. Additionally, the failure to provide meaningful ROI could jeopardize the company's relevance in the market, exacerbating these challenges.
This aggregate rating is based on analysts' research of Health Catalyst Inc and is not a guaranteed prediction by Public.com or investment advice.
HCAT Analyst Forecast & Price Prediction
Start investing in HCAT
Order type
Buy in
Order amount
Est. shares
0 shares